Clinical translation of nanomedicines for brain diseases: Current challenges and future directions

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Engineering precision nanoparticles for drug delivery

Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933 · see citing works

Principles of nanoparticle design for overcoming biological barriers to drug delivery

Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · see citing works

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930 · see citing works

Nanomaterials and nanoparticles: Sources and toxicity

Buzea, C., Pacheco, I. I., & Robbie, K. (2007) · Biointerphases · doi:10.1116/1.2815690 · Cited by 3,789 · see citing works

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076 · see citing works

Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy

Forman, H. J., & Zhang, H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00233-1 · Cited by 2,900 · see citing works

Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586 · see citing works

Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

Hu, C. J., Zhang, L., Aryal, S., Cheung, C., Fang, R. H., & Zhang, L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106634108 · Cited by 2,449 · see citing works

Strategies and challenges for the next generation of antibody–drug conjugates

Beck, A., Goetsch, L., Dumontet, C., & Corvaïa, N. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.268 · Cited by 2,271 · see citing works

Lipid NanoparticlesFrom Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement

Tenchov, R., Bird, R., Curtze, A. E., & Zhou, Q. (2021) · ACS Nano · doi:10.1021/acsnano.1c04996 · Cited by 2,221 · see citing works

Progress and challenges towards targeted delivery of cancer therapeutics

Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220 · see citing works

The blood–brain barrier: Structure, regulation and drug delivery

Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906 · see citing works

Hallmarks of neurodegenerative diseases

Wilson, D. M., Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. (2023) · Cell · doi:10.1016/j.cell.2022.12.032 · Cited by 1,789 · see citing works

The human brain in numbers: a linearly scaled-up primate brain

Herculano-Houzel, S. (2009) · Frontiers in Human Neuroscience · doi:10.3389/neuro.09.031.2009 · Cited by 1,778 · see citing works

Inorganic Nanoparticles for MRI Contrast Agents

Na, H. B., Song, I. C., & Hyeon, T. (2009) · Advanced Materials · doi:10.1002/adma.200802366 · Cited by 1,776 · see citing works

The connectomics of brain disorders

Fornito, A., Zalesky, A., & Breakspear, M. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3901 · Cited by 1,734 · see citing works

The entry of nanoparticles into solid tumours

Sindhwani, S., Syed, A. M., Ngai, J., Kingston, B. R., Maiorino, L., Rothschild, J., MacMillan, P., Zhang, Y., Rajesh, N. U., Hoang, T., et al. (2020) · Nature Materials · doi:10.1038/s41563-019-0566-2 · Cited by 1,732 · see citing works

Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells

Lewin, M., Carlesso, N., Tung, C., Tang, X. S., Cory, D. G., Scadden, D. T., & Weissleder, R. (2000) · Nature Biotechnology · doi:10.1038/74464 · Cited by 1,716 · see citing works

Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases

Saraiva, C., Praça, C., Ferreira, R., Santos, T., Ferreira, L., & Bernardino, L. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.044 · Cited by 1,609 · see citing works

Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia

Jain, R. K. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.006 · Cited by 1,589 · see citing works

12th Annual International Conference on Material Science and Engineering (12th ICMSE)

Wang, K., & Achour, B. (2025) · Trans Tech Publications Ltd. eBooks · doi:10.4028/b-xdtcg5 · Cited by 1,407 · see citing works

The global burden of neurological disorders: translating evidence into policy

Feigin, V. L., Vos, T., Nichols, E., Owolabi, M. O., Carroll, W. M., Dichgans, M., Deuschl, G., Parmar, P., Brainin, M., & Murray, C. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30411-9 · Cited by 1,303 · see citing works

Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects

Barua, S., & Mitragotri, S. (2014) · Nano Today · doi:10.1016/j.nantod.2014.04.008 · Cited by 1,266 · see citing works

Challenges and strategies in anti-cancer nanomedicine development: An industry perspective

Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.04.025 · Cited by 1,246 · see citing works

Targeted drug delivery strategies for precision medicines

Manzari, M. T., Shamay, Y., Kiguchi, H., Rosen, N. X., Scaltriti, M., & Heller, D. A. (2021) · Nature Reviews Materials · doi:10.1038/s41578-020-00269-6 · Cited by 1,201 · see citing works

Pathological mechanisms in progressive multiple sclerosis

Mahad, D., Trapp, B. D., & Lassmann, H. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70256-x · Cited by 1,147 · see citing works

Strategies for delivering therapeutics across the blood–brain barrier

Terstappen, G. C., Meyer, A. H., Bell, R. D., & Zhang, W. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00139-y · Cited by 1,138 · see citing works

Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation

Chehelgerdi, M., Chehelgerdi, M., Allela, O. Q. B., Pecho, R. D. C., Narayanan, J., Rao, D. P., Thamaraikani, T., Vasanthan, M., Viktor, P., Lakshmaiya, N., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01865-0 · Cited by 1,116 · see citing works

Targeting Strategies for Tissue-Specific Drug Delivery

Zhao, Z., Ukidve, A., Kim, J., & Mitragotri, S. (2020) · Cell · doi:10.1016/j.cell.2020.02.001 · Cited by 1,114 · see citing works

Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine

de Almeida, M. S., Sušnik, E., Drašler, B., Taladriz‐Blanco, P., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01127d · Cited by 1,108 · see citing works

Therapeutic Nanoparticles and Their Targeted Delivery Applications

Yetisgin, A. A., Çetinel, S., Zuvin, M., Koşar, A., & Kutlu, Ö. (2020) · Molecules · doi:10.3390/molecules25092193 · Cited by 1,103 · see citing works

Therapeutic efficacy of nanoparticles and routes of administration

Chenthamara, D., Sadhasivam, S., Ramakrishnan, S. G., Krishnaswamy, S., Essa, M. M., Lin, F., & Qoronfleh, M. W. (2019) · Biomaterials Research · doi:10.1186/s40824-019-0166-x · Cited by 1,073 · see citing works

Nanoparticle processing: Understanding and controlling aggregation

Shrestha, S., Wang, B., & Dutta, P. K. (2020) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2020.102162 · Cited by 959 · see citing works

Minireview: Nanoparticles and the Immune System

Zolnik, B. S., González-Fernández, A., Sadrieh, N., & Dobrovolskaia, M. A. (2010) · Endocrinology · doi:10.1210/en.2009-1082 · Cited by 914 · see citing works

Liposome composition in drug delivery design, synthesis, characterization, and clinical application

Large, D. E., Abdelmessih, R. G., Fink, E. A., & Auguste, D. T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113851 · Cited by 886 · see citing works

Biomimetic peptide self-assembly for functional materials

Levin, A., Hakala, T. A., Schnaider, L., Bernardes, G. J. L., Gazit, E., & Knowles, T. P. J. (2020) · Nature Reviews Chemistry · doi:10.1038/s41570-020-0215-y · Cited by 867 · see citing works

Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics

Mi, P. (2020) · Theranostics · doi:10.7150/thno.38069 · Cited by 865 · see citing works

Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafers

Wolinsky, J. B., Colson, Y. L., & Grinstaff, M. W. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.11.031 · Cited by 848 · see citing works

Machine Learning in Drug Discovery: A Review

Dara, S., Dhamercherla, S., Jadav, S. S., Babu, C. M., & Ahsan, M. J. (2021) · Artificial Intelligence Review · doi:10.1007/s10462-021-10058-4 · Cited by 843 · see citing works

In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles

Arami, H., Khandhar, A., Liggitt, D., & Krishnan, K. M. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00541h · Cited by 830 · see citing works

Nanomedicine: Principles, Properties, and Regulatory Issues

Soares, S., Sousa, J., Pais, A. A. C. C., & Vitorino, C. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00360 · Cited by 795 · see citing works

Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers

Fang, J., Islam, W., & Maeda, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.005 · Cited by 757 · see citing works

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody

Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., & Jain, R. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14765 · Cited by 719 · see citing works

Emerging combination strategies with phototherapy in cancer nanomedicine

Xie, Z., Fan, T., An, J., Choi, W., Duo, Y., Ge, Y., Zhang, B., Nie, G., Xie, N., Zheng, T., et al. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00215a · Cited by 718 · see citing works

Current hurdles to the translation of nanomedicines from bench to the clinic

Đorđević, S., Gonzalez, M. M., Conejos‐Sánchez, I., Carreira, B., Pozzi, S., Acúrcio, R. C., Satchi‐Fainaro, R., Florindo, H. F., & Vicent, M. J. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01024-2 · Cited by 715 · see citing works

Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases

Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708 · see citing works

Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs

Dilliard, S. A., & Siegwart, D. J. (2023) · Nature Reviews Materials · doi:10.1038/s41578-022-00529-7 · Cited by 707 · see citing works

Stepwise Recruitment of Transcellular and Paracellular Pathways Underlies Blood-Brain Barrier Breakdown in Stroke

Knowland, D., Arac, A., Sekiguchi, K. J., Hsu, M., Lutz, S. E., Perrino, J., Steinberg, G. K., Barres, B. A., Nimmerjahn, A., & Agalliu, D. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.003 · Cited by 703 · see citing works

Principles in the design of ligand-targeted cancer therapeutics and imaging agents

Srinivasarao, M., Galliford, C. V., & Low, P. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4519 · Cited by 676 · see citing works

Function and therapeutic value of astrocytes in neurological diseases

Lee, H.-G., Wheeler, M. A., & Quintana, F. J. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00390-x · Cited by 662 · see citing works

Nanomaterial-based blood-brain-barrier (BBB) crossing strategies

Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119491 · Cited by 604 · see citing works

Safe Nanoparticles: Are We There Yet?

Najahi‐Missaoui, W., Arnold, R. D., & Cummings, B. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010385 · Cited by 600 · see citing works

Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo

Chen, F., Wang, G., Griffin, J. I., Brenneman, B., Banda, N. K., Holers, V. M., Backos, D. S., Wu, L., Moghimi, S. M., & Simberg, D. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2016.269 · Cited by 599 · see citing works

Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies

Chauhan, V. P., Stylianopoulos, T., Boucher, Y., & Jain, R. K. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114300 · Cited by 597 · see citing works

Microglia and Central Nervous System–Associated Macrophages—From Origin to Disease Modulation

Prinz, M., Masuda, T., Wheeler, M. A., & Quintana, F. J. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-110159 · Cited by 584 · see citing works

Amyloid-β-independent regulators of tau pathology in Alzheimer disease

van der Kant, R., Goldstein, L. S. B., & Ossenkoppele, R. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0240-3 · Cited by 580 · see citing works

Animal models of neurodegenerative diseases

Dawson, T. M., Golde, T. E., & Lagier-Tourenne, C. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0236-8 · Cited by 576 · see citing works

Lipid Nanoparticles for Drug Delivery

Xu, L., Wang, X., Liu, Y., Yang, G., Falconer, R. J., & Zhao, C. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100109 · Cited by 568 · see citing works

Tumor-Derived Extracellular Vesicles Breach the Intact Blood–Brain Barrier via Transcytosis

Morad, G., Carman, C. V., Hagedorn, E. J., Perlin, J. R., Zon, L. I., Mustafaoğlu, N., Park, T., Ingber, D. E., Daisy, C. C., & Moses, M. A. (2019) · ACS Nano · doi:10.1021/acsnano.9b04397 · Cited by 561 · see citing works

Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson’s disease

Qu, M., Lin, Q., Huang, L., Fu, Y., Wang, L., He, S., Fu, Y., Yang, S., Zhang, Z., Zhang, L., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.035 · Cited by 543 · see citing works

Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines

Thi, T. T. H., Suys, E. J. A., Lee, J. S., Nguyen, D. H., Park, K. D., & Truong, N. P. (2021) · Vaccines · doi:10.3390/vaccines9040359 · Cited by 538 · see citing works

The blood-brain barrier and immune function and dysfunction

Banks, W. A., & Erickson, M. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.031 · Cited by 523 · see citing works

Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor

Wiley, D. T., Webster, P. C., Gale, A., & Davis, M. E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307152110 · Cited by 521 · see citing works

RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease

Donahue, J. E., Flaherty, S. L., Johanson, C. E., Duncan, J. A., Silverberg, G. D., Miller, M. C., Tavares, R., Yang, W., Wu, Q., Sabo, E., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0115-3 · Cited by 519 · see citing works

Role of animal models in biomedical research: a review

Mukherjee, P., Roy, S., Ghosh, D., & Nandi, S. K. (2022) · Laboratory Animal Research · doi:10.1186/s42826-022-00128-1 · Cited by 510 · see citing works

Inorganic nanomaterials with rapid clearance for biomedical applications

Wang, X., Zhong, X., Li, J., Liu, Z., & Cheng, L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00461h · Cited by 509 · see citing works

“Combo” nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy

Kemp, J. A., Shim, M. S., Heo, C. Y., & Kwon, Y. J. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.019 · Cited by 508 · see citing works

Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles

Saint-Pol, J., Gosselet, F., Duban-Deweer, S., Pottiez, G., & Karamanos, Y. (2020) · Cells · doi:10.3390/cells9040851 · Cited by 503 · see citing works

Clinical translation of nanomedicines: Challenges, opportunities, and keys

Younis, M. A., Tawfeek, H. M., Abdellatif, A. A. H., Abdel-Aleem, J. A., & Harashima, H. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114083 · Cited by 494 · see citing works

Protein nanoparticles in drug delivery: animal protein, plant proteins and protein cages, albumin nanoparticles

Kianfar, E. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00896-3 · Cited by 479 · see citing works

Polyethylene glycol (PEG): The nature, immunogenicity, and role in the hypersensitivity of PEGylated products

Ibrahim, M. Y., Ramadan, E., Elsadek, N. E., Emam, S. E., Shimizu, T., Ando, H., Ishima, Y., El-Garhy, O. H., Sarhan, H. A., Hussein, A. K., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.031 · Cited by 479 · see citing works

Biocompatible Polymer Nanoparticles for Drug Delivery Applications in Cancer and Neurodegenerative Disorder Therapies

Calzoni, E., Cesaretti, A., Polchi, A., Michele, A. D., Tancini, B., & Emiliani, C. (2019) · Journal of Functional Biomaterials · doi:10.3390/jfb10010004 · Cited by 468 · see citing works

Nanoparticles in Drug Delivery: From History to Therapeutic Applications

Afzal, O., Altamimi, A. S. A., Nadeem, M. S., Alzarea, S. I., Almalki, W. H., Tariq, A., Mubeen, B., Murtaza, B. N., Iftikhar, S., Riaz, N., et al. (2022) · Nanomaterials · doi:10.3390/nano12244494 · Cited by 468 · see citing works

Nanomedicine scale-up technologies: feasibilities and challenges

Paliwal, R., Babu, R. J., & Palakurthi, S. (2014) · AAPS PharmSciTech · doi:10.1208/s12249-014-0177-9 · Cited by 466 · see citing works

Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme

Wolburg, H., Wolburg‐Buchholz, K., Kraus, J., Rascher-Eggstein, G., Liebner, S., Hamm, S., Duffner, F., Grote, E.-H., Risau, W., & Engelhardt, B. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0688-z · Cited by 454 · see citing works

Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies

Sung, Y., Jin, P.-R., Chu, L., Hsu, F., Wang, M.-R., Chang, C. S., Chiou, S.-J., Qiu, J.-T. T., Gao, D.-Y., Lin, C.-C., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0570-3 · Cited by 454 · see citing works

Overcoming blood–brain barrier transport: Advances in nanoparticle-based drug delivery strategies

Ding, S., Khan, A. I., Cai, X., Song, Y., Lyu, Z., Du, D., Dutta, P., & Lin, Y. (2020) · Materials Today · doi:10.1016/j.mattod.2020.02.001 · Cited by 448 · see citing works

Biomimetic and Bioinspired Synthesis of Nanomaterials/Nanostructures

Zan, G., & Wu, Q. (2016) · Advanced Materials · doi:10.1002/adma.201503215 · Cited by 434 · see citing works

Crossing the Blood–Brain Barrier: Recent Advances in Drug Delivery to the Brain

Patel, M. M., & Patel, B. M. (2017) · CNS Drugs · doi:10.1007/s40263-016-0405-9 · Cited by 430 · see citing works

Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier

Vieira, D., & Gamarra, L. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s117210 · Cited by 427 · see citing works

The current state of animal models in research: A review

Robinson, N. B., Krieger, K., Khan, F., Huffman, W., Chang, M., Naik, A., Ruan, Y., Hameed, I., Krieger, K. H., Girardi, L. N., et al. (2019) · International Journal of Surgery · doi:10.1016/j.ijsu.2019.10.015 · Cited by 424 · see citing works

Mammalian Retrovirus-like Protein PEG10 Packages Its Own MRNA and Can Be Pseudotyped for MRNA Delivery

Segel, M., Lash, B., Song, J., Ladha, A., Liu, C. C., Jin, X., Mekhedov, S. L., Macrae, R. K., Koonin, E. V., & Zhang, F. (2021) · Science · doi:10.1126/science.abg6155 · Cited by 423 · see citing works

Delivering the power of nanomedicine to patients today

Germain, M., Caputo, F., Metcalfe, S. M., Tosi, G., Spring, K., Åslund, A., Pottier, A., Schiffelers, R. M., Ceccaldi, A., & Schmid, R. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.007 · Cited by 411 · see citing works

Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems

Villa, C. H., Anselmo, A. C., Mitragotri, S., & Muzykantov, V. R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.007 · Cited by 398 · see citing works

Simultaneous Blood–Brain Barrier Crossing and Protection for Stroke Treatment Based on Edaravone-Loaded Ceria Nanoparticles

Bao, Q., Hu, P., Xu, Y., Cheng, T., Wei, C., Pan, L., & Shi, J. (2018) · ACS Nano · doi:10.1021/acsnano.8b01994 · Cited by 391 · see citing works

The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes

Gribkoff, V. K., & Kaczmarek, L. K. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.021 · Cited by 379 · see citing works

Functionalized Nanomaterials Capable of Crossing the Blood–Brain Barrier

Zha, S., Liu, H., Li, H., Li, H., Wong, K.-L., & All, A. H. (2024) · ACS Nano · doi:10.1021/acsnano.3c10674 · Cited by 378 · see citing works

Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude

Brenner, J. S., Pan, D. C., Myerson, J. W., Marcos-Contreras, O. A., Villa, C. H., Patel, P., Hekierski, H., Chatterjee, S., Tao, J., Parhiz, H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05079-7 · Cited by 371 · see citing works

Extracellular vesicles: A bright star of nanomedicine

Wu, P., Zhang, B., Ocansey, D. K. W., Xu, W., & Qian, H. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120467 · Cited by 368 · see citing works

High-sensitivity nanosensors for biomarker detection

Swierczewska, M., Liu, G., Lee, S., & Chen, X. S. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15238f · Cited by 363 · see citing works

A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma

Kumthekar, P., Ko, C. H., Paunesku, T., Dixit, K., Sonabend, A. M., Bloch, O. G., Tate, M. C., Schwartz, M. A., Zuckerman, L., Lezon, R., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abb3945 · Cited by 356 · see citing works

Current approaches of nanomedicines in the market and various stage of clinical translation

Shan, X., Gong, X., Li, J., Wen, J., Li, Y., & Zhang, Z. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.02.025 · Cited by 342 · see citing works

ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function

Sharma, A., Lyashchenko, A. K., Lü, L., Nasrabady, S. E., Elmaleh, M., Mendelsohn, M. M., Nemes, A., Tapia, J. C., Mentis, G. Z., & Shneider, N. A. (2016) · Nature Communications · doi:10.1038/ncomms10465 · Cited by 339 · see citing works

Development of Pharmaceutical Nanomedicines: From the Bench to the Market

Halwani, A. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010106 · Cited by 337 · see citing works

Human disease models in drug development

Loewa, A., Feng, J. J., & Hedtrich, S. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00063-3 · Cited by 331 · see citing works

Focused ultrasound-mediated drug delivery through the blood–brain barrier

Burgess, A., Shah, K., Hough, O., & Hynynen, K. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1028369 · Cited by 325 · see citing works

Zwitterionic gel encapsulation promotes protein stability, enhances pharmacokinetics, and reduces immunogenicity

Zhang, P., Sun, F., Tsao, C., Liu, S., Jain, P. R., Sinclair, A., Hung, H., Bai, T., Wu, K., & Jiang, S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1512465112 · Cited by 316 · see citing works

Systemic Review of Biodegradable Nanomaterials in Nanomedicine

Su, S., & Kang, P. M. (2020) · Nanomaterials · doi:10.3390/nano10040656 · Cited by 314 · see citing works

Blood-Brain Delivery Methods Using Nanotechnology

Teleanu, D. M., Chircov, C., Grumezescu, A. M., Volceanov, A., & Teleanu, R. I. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040269 · Cited by 314 · see citing works

Challenges in design and characterization of ligand-targeted drug delivery systems

Muro, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.052 · Cited by 308 · see citing works

Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy

Zhou, Y., Zhu, F., Liu, Y., Zheng, M., Wang, Y., Zhang, D., Anraku, Y., Zou, Y., Li, J., Wu, H., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc7031 · Cited by 304 · see citing works

Controlling the biodistribution and clearance of nanomedicines

Cabral, H., Li, J., Miyata, K., & Kataoka, K. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00138-1 · Cited by 303 · see citing works

Transferrin Receptor Ligand-Targeted Toxin Conjugate (Tf-CRM107) for Therapy of Malignant Gliomas

Weaver, M. W., & Laske, D. W. (2003) · Journal of Neuro-Oncology · doi:10.1023/a:1026246500788 · Cited by 299 · see citing works

The Importance of Animal Models in Biomedical Research: Current Insights and Applications

Domínguez-Oliva, A., Hernández-Ávalos, I., Martı́nez-Burnes, J., Olmos-Hernández, A. S., Verduzco-Mendoza, A., & Mota‐Rojas, D. (2023) · Animals · doi:10.3390/ani13071223 · Cited by 297 · see citing works

The Promise of Nanotechnology in Personalized Medicine

Alghamdi, M. A., Fallica, A. N., Virzì, N. F., Kesharwani, P., Pittalà, V., & Greish, K. F. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050673 · Cited by 291 · see citing works

PLGA-Based Nanomedicine: History of Advancement and Development in Clinical Applications of Multiple Diseases

Alsaab, H. O., Alharbi, F., Al-Hibs, A. S., Alanazi, N. B., Alshehri, B. Y., Saleh, M. A., Alshehri, F. S., Algarni, M. A., Almugaiteeb, T., Uddin, M. N., et al. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122728 · Cited by 290 · see citing works

Neurotoxicity of Silica Nanoparticles: Brain Localization and Dopaminergic Neurons Damage Pathways

Wu, J., Wang, C., Sun, J., & Xue, Y. (2011) · ACS Nano · doi:10.1021/nn103530b · Cited by 286 · see citing works

Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment

Wu, Y., Wan, S., Yang, S., Hu, H., Zhang, C., Lai, J., Zhou, J., Chen, W., Tang, X., Luo, J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01746-6 · Cited by 283 · see citing works

Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core

Clark, A. J., & Davis, M. E. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517048112 · Cited by 279 · see citing works

Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin

Boulikas, T. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903114168 · Cited by 277 · see citing works

Nanomedicine in the diagnosis and therapy of neurodegenerative disorders

Kabanov, A. V., & Gendelman, H. E. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.014 · Cited by 277 · see citing works

Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells

Sarin, H., Kanevsky, A. S., Wu, H., Brimacombe, K. R., Fung, S. H., Sousa, A. A., Auh, S., Wilson, C. M., Sharma, K., Aronova, M. A., et al. (2008) · Journal of Translational Medicine · doi:10.1186/1479-5876-6-80 · Cited by 274 · see citing works

Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy

Dash, P., Piras, A. M., & Dash, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.012 · Cited by 266 · see citing works

Bio-inspired engineering of cell- and virus-like nanoparticles for drug delivery

Parodi, A., Molinaro, R., Sushnitha, M., Evangelopoulos, M., Martinez, J. O., Arrighetti, N., Corbo, C., & Tasciotti, E. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.09.020 · Cited by 265 · see citing works

Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation

Ruan, S., Hu, C., Tang, X., Cun, X., Xiao, W., Shi, K., He, Q., & Gao, H. (2016) · ACS Nano · doi:10.1021/acsnano.6b05070 · Cited by 263 · see citing works

Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases

Deng, Y., Zhang, X., Shen, H., He, Q., Wu, Z., Liao, W., & Yuan, M. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00489 · Cited by 263 · see citing works

Bioactive inorganic nanomaterials for cancer theranostics

Pei, Z., Lei, H., & Cheng, L. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00352j · Cited by 263 · see citing works

Glioblastoma Therapy: Past, Present and Future

Obrador, E., Moreno-Murciano, P., Oriol‐Caballo, M., López‐Blanch, R., Pineda, B., Gutiérrez-Arroyo, J., Loras, A., Bonet, L. G. G., Martínez‐Cadenas, C., Estrela, J. M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052529 · Cited by 263 · see citing works

Cancer nanomedicine toward clinical translation: Obstacles, opportunities, and future prospects

Zhang, P., Xiao, Y., Sun, X. F., Lin, X., Koo, S., Yaremenko, A. V., Qin, D., Kong, N., Farokhzad, O. C., & Tao, W. (2022) · Med · doi:10.1016/j.medj.2022.12.001 · Cited by 260 · see citing works

Decreased blood–brain barrier P-glycoprotein function in the progression of Parkinson’s disease, PSP and MSA

Bartels, A. L., Willemsen, A., Kortekaas, R., de Jong, B. M., de Vries, R., de Klerk, O., van Oostrom, J. C. H., Portman, A. T., & Leenders, K. L. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0030-y · Cited by 258 · see citing works

The effects of protein corona on in vivo fate of nanocarriers

Xiao, Q., Zoulikha, M., Qiu, M., Teng, C., Lin, C., Li, X., Sallam, M. A., Xu, Q., & He, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114356 · Cited by 258 · see citing works

Stimulus-responsive sequential release systems for drug and gene delivery

Ahmadi, S., Rabiee, N., Bagherzadeh, M., Elmi, F., Fatahi, Y., Farjadian, F., Baheiraei, N., Nasseri, B., Rabiee, M., Dastjerd, N. T., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100914 · Cited by 250 · see citing works

Key for crossing the BBB with nanoparticles: the rational design

Lombardo, S. M., Schneider, M., Türeli, A. E., & Günday-Türeli, N. (2020) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.11.72 · Cited by 247 · see citing works

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma

Zhang, P., Rashidi, A., Zhao, J., Silvers, C., Wang, H., Castro, B. A., Ellingwood, A., Han, Y., Lopez‐Rosas, A., Ζαννίκου, Μ., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37328-9 · Cited by 241 · see citing works

Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions

Abeysinghe, A. A. D. T., Deshapriya, S., & Udawatte, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117996 · Cited by 239 · see citing works

A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection

Abo‐zeid, Y., Ismail, N. S. M., McLean, G. R., & Hamdy, N. Μ. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105465 · Cited by 238 · see citing works

MR-guided focused ultrasound enhances delivery of trastuzumab to Her2-positive brain metastases

Meng, Y., Reilly, R. M., Pezo, R. C., Trudeau, M., Sahgal, A., Singnurkar, A., Perry, J., Myrehaug, S. D., Pople, C. B., Davidson, B., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj4011 · Cited by 236 · see citing works

Nanomedicine-based commercial formulations: current developments and future prospects

Thapa, R. K., & Kim, J. O. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00607-6 · Cited by 235 · see citing works

P-selectin-targeted nanocarriers induce active crossing of the blood–brain barrier via caveolin-1-dependent transcytosis

Tylawsky, D. E., Kiguchi, H., Vaynshteyn, J., Gerwin, J. N., Shah, J., Islam, T., Boyer, J. A., Boué, D. R., Snuderl, M., Greenblatt, M. B., et al. (2023) · Nature Materials · doi:10.1038/s41563-023-01481-9 · Cited by 233 · see citing works

Cancer nanomedicine: is targeting our target?

Lammers, T., Kiessling, F. M., Ashford, M. B., Hennink, W. E., Crommelin, D. J. A., & Storm, G. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.69 · Cited by 232 · see citing works

Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview

Archie, S. R., Shoyaib, A. A., & Cucullo, L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111779 · Cited by 232 · see citing works

Correlation between mouse age and human age in anti-tumor research: Significance and method establishment

Wang, S., Lai, X., Deng, Y., & Song, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2019.117242 · Cited by 228 · see citing works

Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor

Hultqvist, G., Syvänen, S., Fang, X. T., Lannfelt, L., & Sehlin, D. (2017) · Theranostics · doi:10.7150/thno.17155 · Cited by 224 · see citing works

ROS‐Responsive Polymeric siRNA Nanomedicine Stabilized by Triple Interactions for the Robust Glioblastoma Combinational RNAi Therapy

Zheng, M., Liu, Y., Wang, Y., Zhang, D., Zou, Y., Ruan, W., Yin, J., Tao, W., Park, J. B., & Shi, B. (2019) · Advanced Materials · doi:10.1002/adma.201903277 · Cited by 220 · see citing works

Brain penetrating peptides and peptide–drug conjugates to overcome the blood–brain barrier and target CNS diseases

Zhou, X., Smith, Q. R., & Liu, X. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1695 · Cited by 218 · see citing works

Biomimetic Macrophage Membrane-Camouflaged Nanoparticles Induce Ferroptosis by Promoting Mitochondrial Damage in Glioblastoma

Cao, Z., Liu, X., Zhang, W., Zhang, K., Pan, L., Zhu, M., Qin, H., Zou, C., Wang, W., Zhang, C., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c07555 · Cited by 218 · see citing works

Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function

Spiteri, A. G., Wishart, C. L., Pamphlett, R., Locatelli, G., & King, N. J. C. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02384-2 · Cited by 216 · see citing works

Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo

Stalmans, S., Bracke, N., Wynendaele, E., Gevaert, B., Peremans, K. Y., Burvenich, C., Polis, I., & Spiegeleer, B. M. J. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139652 · Cited by 212 · see citing works

Exposure to copper oxide nanoparticles triggers oxidative stress and endoplasmic reticulum (ER)-stress induced toxicology and apoptosis in male rat liver and BRL-3A cell

Liu, H., Lai, W., Liu, X., Yang, H., Fang, Y., Tian, L., Li, K., Nie, H., Zhang, W., Shi, Y., et al. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.123349 · Cited by 212 · see citing works

Parkinson disease therapy: current strategies and future research priorities

Stocchi, F., Bravi, D., Emmi, A., & Antonini, A. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-01034-x · Cited by 211 · see citing works

Nanotechnology-based strategies for siRNA brain delivery for disease therapy

Zheng, M., Tao, W., Zou, Y., Farokhzad, O. C., & Shi, B. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.01.006 · Cited by 210 · see citing works

Genetically engineered cell membrane–coated nanoparticles for targeted delivery of dexamethasone to inflamed lungs

Park, J. H., Jiang, Y., Zhou, J., Gong, H., Mohapatra, A., Heo, J., Gao, W., Fang, R. H., & Zhang, L. (2021) · Science Advances · doi:10.1126/sciadv.abf7820 · Cited by 208 · see citing works

Grand challenges in nanomedicine

Wu, L., Wang, D., & Li, Z. (2019) · Materials Science and Engineering C · doi:10.1016/j.msec.2019.110302 · Cited by 206 · see citing works

Brain Co‐Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy

Zou, Y., Wang, Y., Xu, S., Liu, Y., Yin, J., Lovejoy, D. B., Zheng, M., Liang, X., Park, J. B., Efremov, Y. M., et al. (2022) · Advanced Materials · doi:10.1002/adma.202203958 · Cited by 204 · see citing works

Apolipoprotein E Peptide-Directed Chimeric Polymersomes Mediate an Ultrahigh-Efficiency Targeted Protein Therapy for Glioblastoma

Jiang, Y., Zhang, J., Meng, F., & Zhong, Z. (2018) · ACS Nano · doi:10.1021/acsnano.8b05265 · Cited by 201 · see citing works

Current Strategies to Enhance Delivery of Drugs across the Blood–Brain Barrier

Teleanu, R. I., Preda, M. D., Niculescu, A.-G., Vladâcenco, O., Radu, C. I., Grumezescu, A. M., & Teleanu, D. M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050987 · Cited by 200 · see citing works

Shared mechanisms across the major psychiatric and neurodegenerative diseases

Wingo, T. S., Liu, Y., Gerasimov, E. S., Vattathil, S. M., Wynne, M. E., Liu, J., Lori, A., Faundez, V., Bennett, D. A., Seyfried, N. T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31873-5 · Cited by 199 · see citing works

A nitric-oxide driven chemotactic nanomotor for enhanced immunotherapy of glioblastoma

Chen, H., Li, T., Liu, Z., Tang, S., Tong, J., Tao, Y., Zhao, Z., Li, N., Mao, C., Shen, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35709-0 · Cited by 198 · see citing works

Vascular Targeting of Nanocarriers: Perplexing Aspects of the Seemingly Straightforward Paradigm

Howard, M. D., Zern, B. J., Anselmo, A. C., Shuvaev, V. V., Mitragotri, S., & Muzykantov, V. R. (2014) · ACS Nano · doi:10.1021/nn500136z · Cited by 197 · see citing works

Smart Nanotherapeutic Targeting of Tumor Vasculature

Li, Z., Di, C., Li, S., Yang, X., & Nie, G. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00283 · Cited by 196 · see citing works

Clinical translation of gold nanoparticles

Zhang, R., Kiessling, F. M., Lammers, T., & Pallares, R. M. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01232-4 · Cited by 195 · see citing works

Artificial intelligence to bring nanomedicine to life

Serov, N., & Vinogradov, V. V. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114194 · Cited by 194 · see citing works

Age-Associated Changes in the Immune System and Blood–Brain Barrier Functions

Erickson, M. A., & Banks, W. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071632 · Cited by 192 · see citing works

Human Models Are Needed for Studying Human Neurodevelopmental Disorders

Zhao, X., & Bhattacharyya, A. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.10.009 · Cited by 192 · see citing works

Phase I Study of GRN1005 in Recurrent Malignant Glioma

Drappatz, J., Brenner, A., Wong, E. T., Eichler, A., Schiff, D., Groves, M. D., Mikkelsen, T., Rosenfeld, S., Sarantopoulos, J., Meyers, C. A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2481 · Cited by 190 · see citing works

Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier

Marcos-Contreras, O. A., Greineder, C. F., Kiseleva, R. Y., Parhiz, H., Walsh, L. R., Zuluaga‐Ramirez, V., Myerson, J. W., Hood, E. D., Villa, C. H., Tombácz, I., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912012117 · Cited by 187 · see citing works

Intrathecal drug delivery in the era of nanomedicine

Fowler, M. J., Cotter, J. D., Knight, B. E., Sevick-Muraca, E. M., Sandberg, D. I., & Sirianni, R. W. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.02.006 · Cited by 187 · see citing works

Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients

Grauer, O. M., Jaber, M., Heß, K., Weckesser, M., Schwindt, W., Maring, S., Wölfer, J., & Stummer, W. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-03005-x · Cited by 186 · see citing works

Intranasal Delivery of Nanoformulations: A Potential Way of Treatment for Neurological Disorders

Islam, S. U., Shehzad, A., Ahmed, M. B., & Lee, Y. S. (2020) · Molecules · doi:10.3390/molecules25081929 · Cited by 184 · see citing works

Dysfunction of the blood–brain barrier in Alzheimer's disease: Evidence from human studies

Kurz, C., Walker, L., Rauchmann, B., & Perneczky, R. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12782 · Cited by 183 · see citing works

Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study

Ramanathan, R. K., Korn, R. L., Raghunand, N., Sachdev, J. C., Newbold, R. G., Jameson, G., Fetterly, G. J., Prey, J., Klinz, S. G., Kim, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1990 · Cited by 183 · see citing works

Nanoparticle-mediated convection-enhanced delivery of a DNA intercalator to gliomas circumvents temozolomide resistance

Wang, Y., Jiang, Y., Wei, D., Singh, P., Yu, Y., Lee, T., Zhang, L., Mandl, H. K., Piotrowski-Daspit, A. S., Chen, X., et al. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00728-7 · Cited by 183 · see citing works

Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review

Yu, T.-W., Lane, H., & Lin, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158208 · Cited by 182 · see citing works

Cell membrane-derived vesicles for delivery of therapeutic agents

Le, Q.-V., Lee, J., Lee, H., Shim, G., & Oh, Y.-K. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.01.020 · Cited by 181 · see citing works

Poly(carboxybetaine) nanomaterials enable long circulation and prevent polymer-specific antibody production

Yang, W. M., Liu, S., Bai, T., Keefe, A. J., Zhang, L., Ella‐Menye, J., Li, Y., & Jiang, S. (2014) · Nano Today · doi:10.1016/j.nantod.2014.02.004 · Cited by 179 · see citing works

An iRGD-conjugated prodrug micelle with blood-brain-barrier penetrability for anti-glioma therapy

Lu, L., Zhao, X., Fu, T., Li, K., He, Y., Luo, Z. Y., Dai, L., Zeng, R., & Cai, K. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119666 · Cited by 177 · see citing works

Single siRNA Nanocapsules for Effective siRNA Brain Delivery and Glioblastoma Treatment

Zou, Y., Sun, X., Wang, Y., Yan, C., Liu, Y., Li, J., Zhang, D., Zheng, M., Chung, R. S., & Shi, B. (2020) · Advanced Materials · doi:10.1002/adma.202000416 · Cited by 177 · see citing works

Genetically Engineered Cell Membrane Nanovesicles for Oncolytic Adenovirus Delivery: A Versatile Platform for Cancer Virotherapy

Lv, P., Liu, X., Chen, X., Liu, C., Zhang, Y., Chu, C., Wang, J., Wang, X., Chen, X. S., & Liu, G. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00145 · Cited by 175 · see citing works

Theranostic AGuIX nanoparticles as radiosensitizer: A phase I, dose-escalation study in patients with multiple brain metastases (NANO-RAD trial)

Verry, C., Dufort, S., Villa, J., Gavard, M., Iriart, C., Grand, S., Charles, J., Chovelon, B., Cracowski, J.-L., Quesada, J.-L., et al. (2021) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2021.04.021 · Cited by 173 · see citing works

Oxidative stress and potential effects of metal nanoparticles: A review of biocompatibility and toxicity concerns

Wang, Y., Lee, Y., Chou, C., Chang, Y., Liu, W., & Chiu, H. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.123617 · Cited by 172 · see citing works

Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system

Wang, C., Xue, Y., Markovic, T., Li, H., Wang, S., Zhong, Y., Du, S., Zhang, Y., Hou, X., Yu, Y., et al. (2025) · Nature Materials · doi:10.1038/s41563-024-02114-5 · Cited by 171 · see citing works

Recent Preclinical and Clinical Progress in Liposomal Doxorubicin

Aloss, K., & Hamar, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030893 · Cited by 171 · see citing works

Convection-enhanced drug delivery for glioblastoma: a review

D’Amico, R. S., Aghi, M. K., Vogelbaum, M. A., & Bruce, J. N. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03408-9 · Cited by 169 · see citing works

Approved Nanomedicine against Diseases

Jia, Y., Jiang, Y., He, Y., Zhang, W., Zou, J., Magar, K. T., Boucetta, H., Teng, C., & He, W. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030774 · Cited by 169 · see citing works

FDA’s Poly (Lactic-Co-Glycolic Acid) Research Program and Regulatory Outcomes

Wang, Y., Qin, B., Xia, G., & Choi, S. H. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00611-y · Cited by 167 · see citing works

Shape effect in active targeting of nanoparticles to inflamed cerebral endothelium under static and flow conditions

da Silva‐Candal, A., Brown, T. D., Krishnan, V., López-Loureiro, I., Ávila-Gómez, P., Pusuluri, A., Pérez, A. C., Correa‐Paz, C., Hervella, P., Castillo, J., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.07.026 · Cited by 166 · see citing works

Targeted Delivery of Nano-Therapeutics for Major Disorders of the Central Nervous System

Gao, H., Pang, Z., & Jiang, X. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1122-4 · Cited by 164 · see citing works

Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo

Johnsen, K. B., Bak, M., Melander, F., Thomsen, M. S., Burkhart, A., Kempen, P. J., Andresen, T. L., & Moos, T. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.005 · Cited by 163 · see citing works

Non-invasive mapping of deep-tissue lymph nodes in live animals using a multimodal PET/MRI nanoparticle

Thorek, D. L. J., Ulmert, D., Diop, N.-F. M., Lupu, M. E., Doran, M. G., Huang, R., Abou, D. S., Larson, S. M., & Grimm, J. (2014) · Nature Communications · doi:10.1038/ncomms4097 · Cited by 163 · see citing works

Precision drug delivery to the central nervous system using engineered nanoparticles

Gao, J., Xia, Z. J., Gunasekar, S., Jiang, C., Karp, J. M., & Joshi, N. (2024) · Nature Reviews Materials · doi:10.1038/s41578-024-00695-w · Cited by 162 · see citing works

Regulating Nanomedicine – Can the FDA Handle It?

Bawa, R. (2011) · Current Drug Delivery · doi:10.2174/156720111795256156 · Cited by 162 · see citing works

Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles

Johnsen, K. B., Bak, M., Kempen, P. J., Melander, F., Burkhart, A., Thomsen, M. S., Nielsen, M. S., Moos, T., & Andresen, T. L. (2018) · Theranostics · doi:10.7150/thno.25228 · Cited by 157 · see citing works

High‐Throughput Continuous Flow Production of Nanoscale Liposomes by Microfluidic Vertical Flow Focusing

Hood, R. R., & DeVoe, D. L. (2015) · Small · doi:10.1002/smll.201501345 · Cited by 156 · see citing works

Overview of Current Drug Delivery Methods Across the Blood–Brain Barrier for the Treatment of Primary Brain Tumors

Haumann, R., Videira, J. C., Kaspers, G. J. L., van Vuurden, D. G., & Hulleman, E. (2020) · CNS Drugs · doi:10.1007/s40263-020-00766-w · Cited by 156 · see citing works

Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics

Mukherjee, S., Madamsetty, V. S., Bhattacharya, D., Roy Chowdhury, S., Paul, M. K., & Mukherjee, A. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202003054 · Cited by 152 · see citing works

Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies

Colombo, M., Fiandra, L., Alessio, G., Mazzucchelli, S., Nebuloni, M., Palma, C. D., Kantner, K., Pelaz, B., Rotem, R., Corsi, F., et al. (2016) · Nature Communications · doi:10.1038/ncomms13818 · Cited by 149 · see citing works

Drug delivery strategies to enhance the permeability of the blood–brain barrier for treatment of glioma

Zhang, F., Xu, C., & Liu, C. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s79592 · Cited by 147 · see citing works

Opening of the Blood–Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models

Sabbagh, A., Beccaria, K., Ling, X., Marisetty, A., Ott, M., Caruso, H. G., Barton, E. A., Kong, L.-Y., Fang, D., Latha, K., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-3760 · Cited by 147 · see citing works

Drug Delivery and Targeting to the Brain Through Nasal Route: Mechanisms, Applications and Challenges

Kashyap, K., & Shukla, R. (2019) · Current Drug Delivery · doi:10.2174/1567201816666191029122740 · Cited by 146 · see citing works

Brain-targeted intranasal delivery of dopamine with borneol and lactoferrin co-modified nanoparticles for treating Parkinson’s disease

Tang, S.-N., Wang, A.-P., Yan, X., Chu, L., Yang, X., Song, Y., Sun, K.-X., Yu, X., Liu, R.-X., Wu, Z., et al. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1636420 · Cited by 144 · see citing works

Activation of endothelial Wnt/β-catenin signaling by protective astrocytes repairs BBB damage in ischemic stroke

Song, S., Huang, H., Guan, X., Fiesler, V. M., Bhuiyan, M. I. H., Liu, R., Jalali, S., Hasan, M. N., Tai, A., Chattopadhyay, A., et al. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101963 · Cited by 144 · see citing works

Claudin-1-Dependent Destabilization of the Blood–Brain Barrier in Chronic Stroke

Sladojević, N., Stamatovic, S. M., Johnson, A., Choi, J. H. K., Hu, A., Dithmer, S., Blasig, I. E., Keep, R. F., & Andjelkovic, A. V. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1432-18.2018 · Cited by 142 · see citing works

Nanomedicine for brain cancer

Quader, S., Kataoka, K., & Cabral, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114115 · Cited by 142 · see citing works

Recent Advances in Nanomaterials-Based Targeted Drug Delivery for Preclinical Cancer Diagnosis and Therapeutics

Tiwari, H., Rai, N., Singh, S., Gupta, P., Verma, A. K., Singh, A. K., Kajal, Salvi, P., Singh, S. K., & Gautam, V. (2023) · Bioengineering · doi:10.3390/bioengineering10070760 · Cited by 141 · see citing works

Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease

Rabiee, N., Ahmadi, S., Afshari, R., Khalaji, S., Rabiee, M., Bagherzadeh, M., Fatahi, Y., Dinarvand, R., Tahriri, M., Tayebi, L., et al. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000076 · Cited by 140 · see citing works

Neurocognitive and somatic stabilization in pediatric patients with severe Mucopolysaccharidosis Type I after 52 weeks of intravenous brain-penetrating insulin receptor antibody-iduronidase fusion protein (valanafusp alpha): an open label phase 1-2 trial

Giugliani, R., Giugliani, L., Poswar, F. D. O., Donis, K. C., Corte, A. D., Schmidt, M., Boado, R. J., Nestrašil, I., Nguyen, C., Chen, S., et al. (2018) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-018-0849-8 · Cited by 140 · see citing works

Dual-targeted nanomedicines for enhanced tumor treatment

Zhu, Y., Feijén, J., & Zhong, Z. (2018) · Nano Today · doi:10.1016/j.nantod.2017.12.007 · Cited by 138 · see citing works

Blood-brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies.

Zierfuss, B., Larochelle, C., & Prat, A. (2024) · Lancet Neurology · doi:10.1016/s1474-4422(23)00377-0 · Cited by 138 · see citing works

Depressive disorders: treatment failures and poor prognosis over the last 50 years

Blackburn, T. P. (2019) · Pharmacology Research & Perspectives · doi:10.1002/prp2.472 · Cited by 136 · see citing works

Stimuli-responsive nanoplatforms for central nervous system disorders: integrating delivery, modulation, and imaging

Chen, Y., Ding, Y., Lin, H., & Shi, J. (2026) · Chemical Society Reviews · doi:10.1039/d5cs01323b · Cited by 9 · see citing works

Biomaterials and Nanoparticle-Based Therapeutics in Neurodegenerative Diseases: Bridging the Gap Between Innovation and Translation

Panchal, D., Solanki, D., Solanki, R., Yadav, A. K., Bhatia, D. D., & Yadav, P. K. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00245 · Cited by 5 · see citing works

Artificial intelligence-assisted lipid nanoparticles formulation in drug delivery for precision therapy

Huang, C., Zuo, W., Xiao, J., Xiong, C., Zhu, L., Su, Y., & Zhan, M. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.100800 · Cited by 3 · see citing works

Nanoparticles in Therapy and Diagnosis: A Comprehensive Review of Mechanisms, Applications, and Translational Challenges

Tiwary, P., Oswal, K., Varghese, R., & Gupta, P. K. (2026) · Journal of Nanotheranostics · doi:10.3390/jnt7020011 · Cited by 3 · see citing works

Advances in Strategies to Transport Nanoparticles Across the Blood–Brain Barrier for Drug Delivery into the Brain for the Treatment of Alzheimer’s Disease

Silva, R., Monteiro, J., Ramalho, M. J., Andrade, S., Loureiro, J. A., & Pereira, M. C. (2026) · Pharmaceuticals · doi:10.3390/ph19050685 · Cited by 2 · see citing works

Nanomedicine for Glioblastoma Therapy: Novel Insights and Future Perspectives

Guo, Y., Lu, K., Luo, W., Wei, M., Li, F., Li, M., Peng, J., Yang, M., Zhao, L., & Zhang, H. (2026) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70071 · Cited by 2 · see citing works

Harnessing Nanocarriers to Improve Psychiatric Treatment: Progress, Limitations, and Future Directions

Ge, X., Zhao, L., Xing, X., Hao, Y., Zhang, Z., & Sun, G. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s600278 · Cited by 1 · see citing works

Macrophage immunometabolism in stroke: a view from single-cell and nano technologies

Zhu, Y., Huang, Z., Li, X., Zhou, J., Lei, X., Liang, F., Yan, J., Deng, H., Sun, X., & Guo, Z. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08412-7 · Cited by 1 · see citing works

The nano-neuro nexus: smart sensors at the frontier of detecting neurodegeneration

Mehrotra, A., Sood, A., Yadav, S., Raval, A. D., Jyothi, S. R., Sah, A. K., Sharma, C., & Maharana, L. (2026) · Frontiers in Nanotechnology · doi:10.3389/fnano.2026.1843615 · Cited by 1 · see citing works

Biomimetic exosomal delivery of ginsenoside Rd reduces post-stroke depression via microglial reprogramming in a pathway involving EGFR/JAK2/STAT3

Chen, J., Yin, X., Dong, Y., Shi, Q., Tan, E., Yan, Z., Zhang, P., Li, W., Xiao, M., Wang, Q., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108376 · Cited by 1 · see citing works

Nanoparticle-Based Drug Delivery Across the Blood–Brain Barrier: Current In Vivo Evidence, Translational Challenges, and Future Perspectives

Al‐allaq, A. A., Hassan, H. A., Hidayet, H. M., Abdulhakeem, A. A., & Ahmad, Z. A.-A. Q. (2026) · Micro · doi:10.3390/micro6030065 · Cited by 1 · see citing works

Oxidative-stress-responsive polymeric nanocarriers for Alzheimer’s disease: emerging antioxidant strategies using NAC and curcumin

Singh, L. K., Singh, S. P., & Sharma, P. (2026) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2026.2644503

Glioblastoma IDH-wildtype: An integrative review of pathophysiological mechanisms, diagnostic innovations, and emerging therapeutic modalities

Dhingra, P., Gupta, G. D., Kumar, A., Patel, P., & Kurmi, B. D. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156471

Harnessing Targeted Protein Degradation for Developing Brain Cancer Therapy

Muhammad, O., White, S., Dumo, C. J., Park, T. I., Choi, P. J., & Jose, J. (2026) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6c00123

Advances in Nanomedicine for X‐Ray‐Based Cancer Therapy: Mechanisms, Challenges, and Opportunities

Alqinnah, M. Y., Shakhreet, B. Z., emam, M., Alhamami, Q. S., Alhazmi, K., Alotaibi, S. A., & Alzahrani, H. M. (2026) · X-Ray Spectrometry · doi:10.1002/xrs.70113

Evaluation of in vitro blood-brain barrier models in central nervous system new drug development: methodological challenges and translational perspectives

Lee, C., Park, D. H., Lee, E. J., Kim, S. H., Seong, Y.-J., Hwang, Y., Won, H., Choi, S. B., Ku, B., Lee, D. W., et al. (2026) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2026.2676068

Advanced nanomedicine-based strategies for glioblastoma management: Targeted delivery, photodynamic therapy, and theranostic integration

Feizy, M., Nehal, N., Haider, F., Khan, M., Khan, M. S., Parveen, R., Amin, S., & Ali, J. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108652

A Sonodynamic Dual‐Prodrug Semiconducting Nanoactivator Inducing Synergistic Ferroptosis‐Pyroptosis Cascade for Enhanced Glioblastoma Therapy

Zhan, Y., Wang, F., Liu, Y., Zhu, A., Liu, J., & Li, J. (2026) · Advanced Functional Materials · doi:10.1002/adfm.77176

Nanomedicine for epilepsy: Expanding beyond conventional drug targets

Sun, Y., & Liu, W. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115219

Emerging nano-drug delivery strategies for management of neuropsychiatric disorders

Jaiswal, A. K., Zai, I., Hasan, N., & Sultana, Y. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108806

Theranostic Innovative Strategies for Brain Diseases: New Insights on Neurovascular Unit-Associated Pathological Changes in Neurodegenerative Disorders and Aging

Terribile, G., Pedrinazzi, M., Frigerio, I., Sancini, G., & Combi, R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167165

Technological Lock-In in Advanced Drug Delivery Systems and Its Role in Translational Failure

Santos, V., Costa, R., & Teixeira, B. (2026) · Journal of Applied Pharmaceutical Technologies and Systems · doi:10.68159/g935757564

In situ transformable fibrillar networks ameliorate secondary brain injury after intracerebral hemorrhage by activating KEAP1-Nrf2/ARE axis

Liu, Y., Zhang, W., Wang, J., Wang, Y., Ji, J., Wang, C., Deng, F., Wu, A., Yang, J., 杜永轩, et al. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124627

Pharmacological modulation of cGAS-STING-NLRP3 signaling by nano-immunomodulators in Alzheimer and Parkinson disease

Abdel-Rasol, M. A. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02386-0

Applications of Prussian blue nanoparticles in the treatment of neurodegenerative diseases

Busquets, M. A., Sabaté, R., Álvarez-Berbel, I., & Espargaró, A. (2026) · Nanomedicine · doi:10.1080/17435889.2026.2734070

Recent advances in biopolymeric nanocarriers based on metallodrugs for therapeutic intervention in neurodegenerative diseases

Aquino, W. C. P., Ribeiro, I. S., Júnior, C. A. L., & de Jesus, J. R. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.07.008

Multitarget approaches in the treatment of Alzheimer’s disease: A new strategy in drug design

Pereira, M. V. S., Ribeiro, I. S., Aquino, W. C. P., Alfredo, L. H. M., da Paixao, Y. F., Despaigne, A. A. R., Moraes, M. N., & de Jesus, J. R. (2026) · Advances in pharmacology · doi:10.1016/bs.apha.2026.07.005

Biomaterial‐Based Controlled Release Systems for Spinal Cord Remyelination

Petillo, E., Veneruso, V., Frigerio, E., Ghirardi, F., Nunziata, G., Giorgi, Z., Rossi, F., & Veglianese, P. (2026) · Advanced Materials · doi:10.1002/adma.75202

Next-Generation Intelligent Adaptive Micro/Nanorobots for Precise Intervention of Central Nervous System Injuries: Advances, Clinical Hurdles, and Future Directions

Liu, S., Huang, Y., & He, Q. Z. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.6c00229

Emerging biotechnological approaches in alcoholic liver disease: natural compounds, delivery systems, and translational potential

Kang, X., Tang, Y., Xue, H., Hong, K., Lin, Y., Han, X., Yuan, X., Huang, W., Zhan, J., Guo, J., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3383-9

Neuroprotective Nanomaterials for Central Nervous System Injury: Beyond Drug Delivery Toward Functional Neurorepair

Colasante, M., Leandro, L. D., d’Angelo, M., Castelli, V., D’Egidio, F., Cimini, A., Ippoliti, R., & Catanesi, M. (2026) · Biomedicines · doi:10.3390/biomedicines14102382

Intranasal nano-immunotherapy for glioma: bypassing the blood–brain barrier, reprogramming the immune microenvironment, and bridging preclinical validation

Li, L., Wu, M., & Li, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1950362

Precision Nanomedicine for Traumatic Neural Injury: Functional Paradigms and Translational Frameworks

Sun, M., Li, S., He, Z., Xie, J., Luo, Y., Fan, X., Zhang, J., Qin, L., Peng, L., Qiu, T., et al. (2026) · Advanced Science · doi:10.1002/advs.78308

Nanoparticulate Drug Delivery Systems to Overcome the Blood–Brain Barrier

Tagami, T., Taki, M., & Ozeki, T. (2015) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3121-7_17 · Cited by 7 · see citing works

Nanoparticle-Based Drug Delivery Across the Blood–Brain Barrier: Current In Vivo Evidence, Translational Challenges, and Future Perspectives

Al‐allaq, A. A., Hassan, H. A., Hidayet, H. M., Abdulhakeem, A. A., & Ahmad, Z. A.-A. Q. (2026) · Micro · doi:10.3390/micro6030065 · Cited by 1 · see citing works

Brain Targeting Nanomedicines: Pitfalls and Promise

Käkinen, A., Jiang, Y., Davis, T. P., Teesalu, T., & Saarma, M. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s454553 · Cited by 24 · see citing works

Getting into the Brain: Are We in Yet or Just Knocking at the Door?

Nagpal, K., Singh, D., Bhatia, A., & Kumar, P. (2021) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2021038918 · Cited by 4 · see citing works

NANOMEDICINE IN TARGETED DRUG DELIVERY FOR NEUROLOGICAL DISORDERS

Sehgal, P. (2017) · Innovations in Pharmacy Planet